Polymeric Based Therapeutic Delivery Systems Prepared Using Electrohydrodynamic Processes

dc.contributor.authorRasekh, M.
dc.contributor.authorNazari, K.
dc.contributor.authorArshad, M. S.
dc.contributor.authorKucuk, I.
dc.contributor.authorHaj-Ahmad, R.
dc.contributor.authorHussain, A.
dc.contributor.authorAhmad, Z.
dc.date.accessioned2026-08-12T17:32:52Z
dc.date.issued2016
dc.departmentFırat Üniversitesi
dc.description.abstractThe development of therapeutic dosage (e.g. pharmaceutical) systems is an ongoing process which, in recent times has incorporated several emerging disciplines and themes at timely intervals. While the concepts surrounding dosage forms have developed and evolved, many polymeric excipients remain as the preferred choice of materials over existing counterparts, serving functions as matrix materials, coatings and providing other specific functional properties (e.g. adhesion, controlled release and mechanical properties). There have been, however, developments in the deployment of synthetic polymeric materials (e.g. polycaprolactone, poly lactic co-glycolic acid) when compared to naturally occurring materials (e.g. lactose, gelatin). Advances in pharmaceutical process technologies have also provided novel engineering platforms to develop a host of exciting structure based materials ranging from the nanometer to the macro scales. Some of these structure enabling technologies include spray drying, super critical processing, microfluidics and even wet chemical methods. More recently electrohydrodynamic (EHDA) engineering methods have emerged as robust technologies offering potential to fabricate a plethora of generic structures (e.g. particles, fibres, bubbles and pre-determined patterns) on a broad scale range. This review focuses on key developments using various EHDA technologies for the pharmaceutical and biomaterial remits when selecting synthetic and/or naturally occurring polymers as pharmaceutical (and therapeutic) excipients. In addition, the underlying EHDA process principles are discussed along with key parameters and variables (both materials and engineering). EHDA technologies are operational at ambient conditions and recent developments have also demonstrated their viability for large scale production. These are promising technologies which have potential in established (e.g. films, dressings and microparticles) and emerging scientific themes (e.g. nanomedicines and tissue engineering).
dc.identifier.doi10.2174/1381612822666160217141612
dc.identifier.endpage2885
dc.identifier.issn1381-6128
dc.identifier.issn1873-4286
dc.identifier.issue19
dc.identifier.orcid0009-0009-1415-3722
dc.identifier.orcid0000-0002-1284-8880
dc.identifier.orcid0000-0001-6600-9292
dc.identifier.orcid0000-0002-5465-0215
dc.identifier.orcid0000-0001-8863-6211
dc.identifier.orcid0000-0002-0137-8895
dc.identifier.pmid26898734
dc.identifier.scopus2-s2.0-84969170549
dc.identifier.scopusqualityQ2
dc.identifier.startpage2873
dc.identifier.urihttps://doi.org/10.2174/1381612822666160217141612
dc.identifier.urihttps://hdl.handle.net/11508/56802
dc.identifier.volume22
dc.identifier.wosWOS:000376452700010
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherBentham Science Publ Ltd
dc.relation.ispartofCurrent Pharmaceutical Design
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectElectrohydrodynamic
dc.subjectfibres
dc.subjectparticles
dc.subjectbubbles
dc.subjectprinting
dc.subjectdrug delivery
dc.subjectencapsulation
dc.subjectnatural polymers and synthetic polymers
dc.subjectactives
dc.subjectprocessing
dc.subjectengineering
dc.titlePolymeric Based Therapeutic Delivery Systems Prepared Using Electrohydrodynamic Processes
dc.typeArticle

Dosyalar